234 related articles for article (PubMed ID: 37054905)
21. Non-coding RNAs: key players in cardiac disease.
Kreutzer FP; Fiedler J; Thum T
J Physiol; 2020 Jul; 598(14):2995-3003. PubMed ID: 31291008
[TBL] [Abstract][Full Text] [Related]
22. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
23. Roles of non-coding RNA in megakaryocytopoiesis and thrombopoiesis: new target therapies in ITP.
Li W; Lv Y; Sun Y
Platelets; 2023 Dec; 34(1):2157382. PubMed ID: 36550091
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Mutant p53 in the Non-Coding RNA World.
Di Agostino S
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32204575
[TBL] [Abstract][Full Text] [Related]
25. Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis.
Tao H; Yang JJ; Shi KH
Expert Opin Ther Targets; 2015 May; 19(5):707-16. PubMed ID: 25652534
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic targeting of non-coding RNAs in cancer.
Slaby O; Laga R; Sedlacek O
Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
[TBL] [Abstract][Full Text] [Related]
27. Non-coding RNA-based regulation of inflammation.
Ashrafizadeh M; Zarrabi A; Mostafavi E; Aref AR; Sethi G; Wang L; Tergaonkar V
Semin Immunol; 2022 Jan; 59():101606. PubMed ID: 35691882
[TBL] [Abstract][Full Text] [Related]
28. Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions.
HajiEsmailPoor Z; Tabnak P; Ahmadzadeh B; Ebrahimi SS; Faal B; Mashatan N
Biomed Pharmacother; 2022 Sep; 153():113507. PubMed ID: 36076513
[TBL] [Abstract][Full Text] [Related]
29. The roles of non-coding RNAs in vascular calcification and opportunities as therapeutic targets.
Ryu J; Ahn Y; Kook H; Kim YK
Pharmacol Ther; 2021 Feb; 218():107675. PubMed ID: 32910935
[TBL] [Abstract][Full Text] [Related]
30. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
[TBL] [Abstract][Full Text] [Related]
31. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
Razavi ZS; Tajiknia V; Majidi S; Ghandali M; Mirzaei HR; Rahimian N; Hamblin MR; Mirzaei H
Crit Rev Oncol Hematol; 2021 Jan; 157():103192. PubMed ID: 33290823
[TBL] [Abstract][Full Text] [Related]
32. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication.
Klinge CM
Noncoding RNA; 2018 Dec; 4(4):. PubMed ID: 30545127
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications.
Liu Y; Leng P; Liu Y; Guo J; Zhou H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555400
[TBL] [Abstract][Full Text] [Related]
34. Regulatory non-coding RNAs: a new frontier in regulation of plant biology.
Bhogireddy S; Mangrauthia SK; Kumar R; Pandey AK; Singh S; Jain A; Budak H; Varshney RK; Kudapa H
Funct Integr Genomics; 2021 Jul; 21(3-4):313-330. PubMed ID: 34013486
[TBL] [Abstract][Full Text] [Related]
35. Non-coding RNA dysregulation in skin cancers.
Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
[TBL] [Abstract][Full Text] [Related]
36. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
[TBL] [Abstract][Full Text] [Related]
37. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs.
Sharma U; Tuli HS; Uttam V; Choudhary R; Sharma B; Sharma U; Prakash H; Jain A
Pharmacol Res; 2022 Dec; 186():106523. PubMed ID: 36377125
[TBL] [Abstract][Full Text] [Related]
38. Pluripotency Crossroads: Junction of Transcription Factors, Epigenetic Mechanisms, MicroRNAs, and Long Non-coding RNAs.
Rad SM; Mohammadi-Sangcheshmeh A; Bamdad T; Langroudi L; Atashi A; Lotfinia M; Arefian E; Gastal EL; Soleimani M
Curr Stem Cell Res Ther; 2017; 12(4):300-311. PubMed ID: 25986623
[TBL] [Abstract][Full Text] [Related]
39. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
Grillone K; Riillo C; Scionti F; Rocca R; Tradigo G; Guzzi PH; Alcaro S; Di Martino MT; Tagliaferri P; Tassone P
J Exp Clin Cancer Res; 2020 Jun; 39(1):117. PubMed ID: 32563270
[TBL] [Abstract][Full Text] [Related]
40. Double-edged effects of noncoding RNAs in responses to environmental genotoxic insults: Perspectives with regards to molecule-ecology network.
Huang R; Zhou P
Environ Pollut; 2019 Apr; 247():64-71. PubMed ID: 30654255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
